wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33207433-24E76A18-1069-4242-A21B-57E4CD5B822C
Q33207433-24E76A18-1069-4242-A21B-57E4CD5B822C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33207433-24E76A18-1069-4242-A21B-57E4CD5B822C
Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumours.
P2860
Q33207433-24E76A18-1069-4242-A21B-57E4CD5B822C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33207433-24E76A18-1069-4242-A21B-57E4CD5B822C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7eccec39f57a8db8d41613af1f8634dd2a393e0c
P2860
Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors.